metformin has been researched along with exudates in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, M; Day, RO; Duong, JK; Furlong, TJ; Graham, GG; Greenfield, JR; Greenup, LC; Kirkpatrick, CM; Kumar, SS; Lee, TC; Timmins, P; Williams, KM | 1 |
| Feng, P; Han, P; Jin Kui, Y; Liu, X; Lv, X; Niemoeller, E; Shang, S; Su, B; Tian, H; Yan, S; Yu Pan, C; Zhou, Z | 1 |
| Dieu Van, NK; Han, P; Ji, L; Liu, Y; Meininger, G; Qiu, R; Vijapurkar, U; Yang, G | 1 |
| Atiomo, W; Chapman, C; Ghani, NA; Hatta, AZ; Malik, DA; Mokhtar, NM; Omar, MH; Seedhouse, C; Shafiee, MN; Yunos, RI | 1 |
| Ahmed, RH; Al-Hamodi, Z; Huri, HZ; Muniandy, S; Salem, SD | 1 |
| Huang, CN; Ji, L; Kadir, AA; Kim, DJ; Kuang, J; Lee, D; Li, L; Yang, T | 1 |
| Abu Bakar, AB; Md Lazin, MRML; Mohamed, M; Nna, VU | 1 |
| Bakar, ABA; Mohamed, M; Nna, VU | 1 |
| Ang, K; Chan, C; Gurung, RL; Lim, SC; Liu, JJ; Liu, S; Sum, CF; Tang, WE; Tavintharan, S; Yeo, D | 1 |
4 trial(s) available for metformin and exudates
| Article | Year |
|---|---|
Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Malaysia; Membrane Transport Proteins; Metformin; Middle Aged; Models, Biological; Nonlinear Dynamics; Polymorphism, Single Nucleotide; Renal Insufficiency; Tissue Distribution; White People; Young Adult | 2013 |
Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double-blind, placebo-controlled, 24-week trial (GetGoal-M-Asia).
Topics: Adult; China; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Malaysia; Male; Metformin; Middle Aged; Nausea; Peptides; Receptors, Glucagon; Sulfonylurea Compounds; Thailand | 2014 |
Canagliflozin in Asian patients with type 2 diabetes on metformin alone or metformin in combination with sulphonylurea.
Topics: Aged; Canagliflozin; China; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glucosides; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Malaysia; Male; Membrane Transport Modulators; Metformin; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiophenes; Vietnam | 2015 |
Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial.
Topics: China; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diabetic; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Exercise; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Immunity, Mucosal; Incidence; Malaysia; Metformin; Middle Aged; Piperidines; Republic of Korea; Respiratory Tract Infections; Taiwan; Uracil | 2017 |
5 other study(ies) available for metformin and exudates
| Article | Year |
|---|---|
The effect of Metformin on endometrial tumor-regulatory genes and systemic metabolic parameters in polycystic ovarian syndrome--a proof-of-concept study.
Topics: Adult; Biopsy; Body Mass Index; Cohort Studies; Cyclin D2; Endometrial Neoplasms; Endometrium; Female; Follicular Phase; Humans; Hypoglycemic Agents; Malaysia; Metformin; Overweight; Polycystic Ovary Syndrome; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Risk; Tumor Suppressor Protein p53; Up-Regulation; Weight Loss; Young Adult | 2015 |
Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects.
Topics: Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Fasting; Female; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Malaysia; Male; Metabolic Syndrome; Metformin; Middle Aged; Solubility | 2015 |
Antioxidant, anti-inflammatory and synergistic anti-hyperglycemic effects of Malaysian propolis and metformin in streptozotocin-induced diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Caspase 3; Diabetes Mellitus, Experimental; Drug Synergism; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Insulin; Interleukin-1; Islets of Langerhans; Malaysia; Male; Malondialdehyde; Metformin; NF-kappa B; Proliferating Cell Nuclear Antigen; Propolis; Rats, Sprague-Dawley; Streptozocin | 2018 |
Malaysian propolis, metformin and their combination, exert hepatoprotective effect in streptozotocin-induced diabetic rats.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Diabetes Mellitus, Experimental; Drug Combinations; Hepatocytes; Hypoglycemic Agents; Liver; Malaysia; Male; Metformin; Oxidative Stress; Propolis; Protective Agents; Rats; Rats, Sprague-Dawley | 2018 |
Clinical Determinants of Diabetes Progression in Multiethnic Asians with Type 2 Diabetes - A 3-Year Prospective Cohort Study.
Topics: Adult; Age of Onset; Aged; Area Under Curve; Asian People; China; Cohort Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Drug Therapy, Combination; Ethnicity; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; India; Insulin; Logistic Models; Longitudinal Studies; Malaysia; Male; Metformin; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Singapore; Sulfonylurea Compounds; Thiazolidinediones | 2019 |